EzriCare Artificial Tears Eye Infection Lawsuit

EzriCare and Delsam Pharma artificial tears eye infection lawsuit

Published: June 22, 2023 · Updated: June 18, 2026

▼ Allegations Only · No Settlement Yet

This page describes a product recall and ongoing litigation. The statements below are unproven allegations. No defendant has been found liable, there is no certified class or approved settlement, and eligibility depends on the facts of each case. This page is informational and is not legal or medical advice.

Status Litigation Ongoing · Winding Down no MDL, no settlement · many firms have stopped accepting new cases

Products Recalled artificial tears EzriCare & Delsam Pharma Artificial Tears (Global Pharma Ltd.)

Alleged Injury Drug-resistant eye infection vision loss, eye removal, hospitalization, and deaths reported

Estimated Payout Varies depends on injury severity and the facts of each case

What Is This About?

Did you use EzriCare Artificial Tears to treat dry or irritated eyes and develop an eye infection? Law firms investigated and have pursued claims that EzriCare Artificial Tears Lubricant Eye Drops caused serious eye infections. EzriCare was sold over the counter to relieve dry and irritated eyes. A significant number of users developed antibiotic-resistant eye infections after using the drops, and some infections became so severe they led to permanent vision loss, surgical removal of the eye, hospitalization, and death when the infection reached the bloodstream.

In early 2023, the manufacturer issued an urgent notice warning users to discontinue use of EzriCare Artificial Tears Lubricant Eye Drops (carboxymethylcellulose sodium, 10 mg in 1 mL). The FDA, the CDC, and the parent company Global Pharma Ltd. warned consumers and health-care providers to stop buying and using EzriCare Artificial Tears due to potential bacterial contamination.

Reported Injuries

According to the CDC and FDA, the contaminated drops were associated with serious consumer injuries, including:

• Severe eye damage
• Vision loss
• Serious bacterial infections
• Surgical removal of the eye
• Death

Possible symptoms of infection included eye pain or discomfort, redness or discharge, headaches, and vision problems. The CDC reported that EzriCare drops were found to contain a drug-resistant strain of bacteria known as VIM-GES-CRPA (a form of Pseudomonas aeruginosa), identified in multiple batches of product collected from users with and without eye infections.

Anyone experiencing symptoms of an eye infection should seek medical care promptly. Quality or adverse-event reports can be submitted to the FDA through its MedWatch reporting system.

Current Status of the Litigation

As of 2026, EzriCare and Delsam Pharma cases have not been consolidated into a multidistrict litigation, and there is no certified class action or approved settlement. Individual lawsuits continue to be filed, but the litigation has slowed and many law firms have stopped accepting new EzriCare cases. Statutes of limitations vary by state, so anyone who believes they were injured should speak with an attorney as soon as possible.

Frequently Asked Questions

Why were EzriCare artificial tears recalled?

In early 2023, the FDA and CDC linked EzriCare and Delsam Pharma Artificial Tears to a multistate outbreak of drug-resistant Pseudomonas aeruginosa (VIM-GES-CRPA). The products, made by Global Pharma Ltd., were recalled, and consumers were urged to stop using them. The outbreak was associated with severe eye infections, vision loss, surgical removal of eyes, and deaths.

Who may qualify for an EzriCare lawsuit?

People who used recalled EzriCare or Delsam Pharma Artificial Tears and developed a serious eye infection, vision loss, or related hospitalization — or families of those who died — may qualify. Eligibility depends on the diagnosis, the product used, and the facts of each case.

What is the current status of the EzriCare litigation?

As of 2026, EzriCare cases have not been consolidated into a multidistrict litigation and there is no certified class action or approved settlement. Individual lawsuits continue to be filed, but the litigation has slowed and many firms have stopped accepting new cases. Statutes of limitations vary by state.

Important Disclosures

This page is for general informational purposes and does not constitute medical or legal advice. If you have symptoms of an eye infection, seek medical care promptly. You should consult a qualified attorney about your individual situation. OpenClassActions.com is not a law firm and is not a claims administrator, and this page does not create an attorney-client relationship.

Free settlement alerts

Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.